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Abstract 
KI and WU are two recently-described human polyomaviruses worldwide distributed. 
An association between these two viruses and respiratory infections has been 
suggested, in particular in children and immunocompromised patients. Since no 
standardized detection methods are currently available, we developed a duplex real-
time PCR assay for the simultaneous detection of KIHPyV and WUHPyV 
polyomaviruses based on TaqMan probes. We assessed this technique on 831 
nasopharyngeal aspirate specimens from hospitalized paediatric patients with 
respiratory symptoms, retrospectively analysed with commercial multiplex assay for 16 
other major respiratory viruses. Our assay detected 500 copies/mL for both KIHPyV 
and WUHPyV in all tested samples. 
We detected KIHPyV and WUHPyV genome in 28 (3.36%) and 41 samples (4.93%) 
respectively. Moreover, in 3 samples, the co-infection of the two viruses was found. 
55 out of all positive samples (n=69) for KIHPyV and/or WUHPyV infection 
exhibited a co-infection with one or more respiratory viruses, confirming that KIHPyV 
and WUHPyV were often detected in association with other viral infections. 
Interestingly, KIHPyV and WUHPyV were detected singularly in 8 out of 28 cases and 
6 out of 41 cases, respectively, suggesting a possible direct role of these viruses in the 
respiratory diseases.  
In conclusion, this method could be taken into account as an alternative technical 
approach to detect KIHPyV and/or WUHPyV in respiratory samples helping in the 
definition of the pathogenic potential and of the epidemiological prevalence of these 
two viruses. 
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Sommario 
KIHPyV e WUHPyV sono due polyomavirus umani recentemente isolati con una 
grande prevalenza nella popolazione mondiale. Fin dalla loro scoperta, KIHPyV e 
WUHPyV sono stati associati a patologie dell’apparato respiratorio soprattutto in 
bambini e soggetti immunocompromessi, ma non esistono ad oggi metodi commerciali 
e/o standardizzati per la diagnosi di KIHPyV e WUHPyV. 
Abbiamo dunque messo a punto una originale Duplex Real-Time PCR in grado di 
identificare e discriminare KIHPyV e WUHPyV con una sensibilità di 500 copie/ml 
ed una specificità del 100%. 
Questa metodica è stata valutata su 831 aspirati nasofaringei di bambini di età inferiore 
a 5 anni con sintomatologie respiratorie. Gli stessi campioni sono stati analizzati in 
maniera retrospettiva con il kit diagnostico standardizzato attualmente in uso per la 
diagnosi di virus respiratori. 
La nostra metodica ha identificato la presenza di KIHPyV in 28 campioni (3.36%) e di 
WUHPyV in 41 campioni (4.93%) mentre in tre campioni è stato possibile rilevare la 
presenza di entrambi i virus. 
Nonostante in 55 dei 69 campioni positivi per KIHPyV e/o WUHPyV siano stati 
anche identificati altri virus, confermando l’alto tasso di identificazione di co- infezione 
di KIHPyV e WUHPyV, è interessante notare che questi sono stati identificati 
singolarmente in 8 casi su 28 ed in 6 casi su 41, rispettivamente. L’identificazione 
singola di KIHPyV e WUHPyV in campioni di bambini con sintomi respiratori 
suggerisce che questi virus possano essere direttamente responsabili dell’insorgenza 
della sintomatologia. 
In conclusione, abbiamo messo a punto un metodo in grado di identificare KIHPyV 
e WUHPyV con elevate sensibilità e specificità, che potrebbe contribuire alla 
definizione del potenziale patogeno e dell’epidemiologia dei due virus. 
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1. INTRODUCTION 
 
1.1 ACUTE RESPIRATORY TRACT INFECTION 
Acute respiratory tract infections (ARI) represent an important global health issue and 
are responsible for significant morbidity and mortality worldwide. Word Health 
Organization (WHO) defines ARI as follows: Acute is defined as sudden onset of 
symptoms; Respiratory and Infection are defined as having at least one of the following 
symptoms: 
 cough; 
 sore throat; 
 shortness of breath; 
 coryza. 
ARI includes a group of diseases that affect millions of people worldwide and could 
exert influence on the survival and the health of many of them, especially kids, elderly 
and immunocompromised patients. In fact, ARI is the most common cause of death 
in children after neonatal complications. 
According with WHO’s report, pneumonia, the most severe ARI form, accounts for 
16% of all the deaths in children under 5 years old. Only in 2016, 880.000 children 
died from acute respiratory infections. 
Although most of the mortality associated with ARI occurs in developing countries, 
considering that the true burden of disease is often underestimated in these areas, there 
are substantial economic issues associated to the spread of respiratory infections also 
in developed countries. In fact, respiratory diseases are accountable for more than 10% 
of all disability-adjusted life-years (DALYs), a metric that estimates the amount of 
active and productive life lost due to a condition (WHO, 2016). 
For example, taking into account common cold, although it mainly causes mild and 
self-limiting symptoms, it led to loss of productivity and work absenteeism not only in 
patients, but also in care givers. Another important aspect that must be considered is 
the treatment cost, in fact respiratory infection is the most common reason for 
antibiotic prescription even though most of the case are of viral etiology, as will be 
extensively discuss in next chapters (Lindbaek, 2006). 
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 1.1.1 Agents of respiratory infection 
Pathogenic agents of acute respiratory infections are viruses, bacteria and fungi. 
Respiratory viruses are the most common causative agents of respiratory infections 
and their distribution differ by season, geographic region and age group (Fouchier et 
al. 2005; Brodzinski & Ruddy 2009; Cerone et al. 2017). Respiratory viruses can cause 
infections in either the upper or lower respiratory tract. Many of them cause common 
clinical syndromes including nasal congestion, cough, sore throat and fever; some of 
these pathogens may also lead to more serious clinical manifestations, such as 
bronchiolitis and pneumonia (Ruuskanen et al. 2011). 
More than 300 different virus serotypes have been associated with human respiratory 
disease. Most common DNA Respiratory virus are human Adenovirus (ADV) and 
human Bocavirus (HBoV), while RNA Respiratory virus are Flu A (A-H1, A-H1N1 
pdm09, A-H3) and B, human Parainfluenzavirus 1-4 (PIV1-4), Respiratory syncytial 
virus A and B (RSV-A, RSV-B), human Metapneumovirus (MPV), human Rhinovirus 
(HRV), human Enterovirus (hEV), human Coronavirus (CoV-229E, CoV- OC43, 
CoV NL63). In the pediatric population, respiratory syncytial virus, parainfluenza 
viruses, and Flu virus are known as the major causes of bronchiolitis and lower 
respiratory tract infections (Brodzinski & Ruddy 2009). 
However, in approximately the 30% of all reported cases of respiratory diseases, none 
of the previous indicated viruses can be revealed, suggesting the existence of additional 
respiratory viruses (Wright et al. 1989; Nokso‐Koivisto et al. 2002). Thanks to the 
advent of high throughput sequencing, new viruses have been recently described both 
in the respiratory tract and in other human district in people showing unknown 
etiology respiratory symptoms, such as Karolinska Institutet Polyomavirus (KIHPyV) 
(T. Allander et al. 2007) and Washington University Polyomavirus (WUHPyV) (Anne 
M Gaynor et al. 2007). 
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 1.1.2 Diagnosis of viral respiratory infections 
Typical respiratory illness diagnosis is clinical, based on symptoms and local 
epidemiology.  Diagnosis of such pathogens is very challenging due to the lack of 
pathognomonic features, the co-circulation of respiratory pathogens and the wide 
range of non-specific symptoms of respiratory infections. Moreover, lack in 
appropriate differential diagnosis lead to difficulties in the administration of 
appropriate antiviral or antibacterial therapy, initiation of effective infection control 
measures and reduction of the length of hospital stay (Das et al. 2018). 
Historically, conventional testing methods for viral diagnosis were: culture and virus 
isolation, which was considered the “gold standard” for diagnosis of respiratory viral 
pathogens (Olsen et al. 1993); viral detection by electron microscopy (Roingeard 2008); 
antigen detection assays like rapid immunoassays (Weinberg & Walker 2005); direct 
and indirect immunofluorescence assays (Weinberg & Walker 2005). 
However, nowadays an increasing number of laboratories is adopting rapid molecular 
assays (Mahony et al. 2011). In particular, Multiplex Real Time PCR (RT-PCR) 
respiratory panel is the most popular diagnostic assay for improving infection control, 
timely treatment decisions and also because it is substantially less expensive than 
detecting individual pathogens. Nucleic acid-based FDA-approved diagnostic tests are 
listed in Table 1 (modified from Das et al. 2018). 
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Test Manufacturer Technology Targets 
AllplexTM Seegene MuDT technology Multiplex Panel (16 tagets) 
Anyplex RV16 Seegene TOCE technology Multiplex Panel (16 targets) 
NxTAG® respiratory pathogen panel Luminex Corporation Real-time RT-PCR Multiplex Panel (20 targets) 
eSensor® respiratory viral panel (RVP) GenMark Diagnostics 
Multiplex microarray, 
competitive DNA 
hybridization 
Multiplex Panel (14 targets) 
Verigene® RP flex Luminex Corporation 
RT-PCR & and microarray 
hybridization 
Multiplex Panel (16 targets) 
ePlex® respiratory pathogen (RP) panel GenMark Diagnostics RT-PCR Multiplex Panel (17 targets) 
FilmArray® respiratory panel (RP) BioFire Diagnostics, Inc., Nested multiplex RT-PCR Multiplex Panel (20 targets) 
FilmArray® respiratory panel 2 (RP2) BioFire Diagnostics, Inc., Nested multiplex RT-PCR Multiplex Panel (21 targets) 
FilmArray® respiratory panel® (RP) EZ BioFire Diagnostics, Inc., Nested multiplex RT-PCR Multiplex Panel (14 targets) 
Lyra® parainfluenza virus assay Quidel Corporation Real-time RT-PCR Parainfluenza virus types 1, 2, and 3 
Lyra® RSV + MPV assay Quidel Corporation Real-time RT-PCR RSV, MPV 
SimplexaTM flu A/B & RSV Kit Focus Diagnostics, Inc., Real-time RT-PCR Flu A, Flu B, and RSV 
Panther fusion flu A/B/RSV Hologic, Inc., Real-time RT-PCR Flu A, Flu B, and RSV 
Panther fusion paraflu assay Hologic, Inc., Real-time RT-PCR Parainfluenza 1, 2, and 3 
Panther fusion AdV/MPV/RV assay Hologic, Inc., Real-time RT-PCR Adenovirus, MPV, and Rhinovirus 
ARIES® flu A/B & RSV assay Luminex Corporation Real-time PCR Flu A, Flu B, and RSV 
SimplexaTM flu A/B & RSV direct Focus Diagnostics, Inc., Real-time RT-PCR Flu A, Flu B, and RSV 
Xpert® flu/RSV XC Cepheid Real-time RT-PCR Flu A, Flu B, and RSV 
Solana RSV + MPV assay Quidel Corporation 
Isothermal RT-helicase-
dependent amplification 
(HDA) 
RSV, MPV 
Illumigene®mycoplasma direct DNA 
amplification assay 
Meridian Bioscience, Inc., 
Loop-mediated isothermal 
DNA amplification (LAMP) 
Mycoplasma pneumoniae 
Xpert® xpress Flu/RSV Cepheid Real-time RT-PCR Flu A, Flu B, and RSV 
Xpert® xpress flu Cepheid Real-time RT-PCR Flu A, Flu B 
cobas® Lia tinfluenza A/B & RSV assay 
Roche Molecular 
Diagnostics 
Real-time RT-PCR Flu A, Flu B, and RSV 
cobas® Liat influenza A/B assay 
Roche Molecular 
Diagnostics 
Real-time RT-PCR Flu A, Flu B 
Alere i influenza A & B 2 test Abbott Laboratories 
Isothermal nucleic acid 
amplification 
Flu A, Flu B 
Alere i RSV Abbott Laboratories 
Isothermal nucleic acid 
amplification 
RSV 
Table 1. Commercially available nucleic acid amplification assays for respiratory pathogens 
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 1.1.3 Seasonality of respiratory infection 
In temperate regions, respiratory viruses mostly show distinct seasonal patterns:  
 Typically, Flu viruses occur mainly during winter causing annual-recurrent 
epidemics in temperate areas, or more irregularly outbreaks in tropical regions. 
Aerosol transmission is facilitated in cold and dry climate, which is one reason for 
the seasonal epidemics during winter (Sundell et al. 2016). However, successive 
outbreaks are not comparable in magnitude and form with each other (Truscott et 
al. 2012). 
 Comparably, RSV tends to peak during winters in temperate regions while exhibits 
a wide range of variability in the timing and duration of epidemics in the tropics, 
where viral circulation is seen primarily during the rainy season (Obando-Pacheco 
et al. 2018; Rose et al. 2018).  
 Surveillance data from CDC’s National Respiratory and Enteric Virus Surveillance 
System (NREVSS) shows that MPV is most active during late winter and spring in 
temperate climates; a biennial epidemic pattern of early and late MPV infection is 
suggested. 
 PIV-1 and PIV-2 also shows fairly regular biennial seasonality with increased 
activity while PIV-3 infections have a regular annual seasonal peak between March 
and June and PIV-4 shows a peak in the last quarter of the year (Zhao et al. 2017).  
 HEV typically shows late summer or early autumn seasonality (Fisman 2012). 
 Higher incidence for HRV infection has been described from September to 
November and from April to May, but in some years (and in some geographical 
areas) spring was reported to be the more important time for HRV transmission 
(Rossi & Colin 2015). On the other hand, all HRV species have been identified in 
all months, independently on the climate regions (Jacobs et al. 2013). 
 Also HBoV and ADV (Schildgen et al. 2008) infections have not a regular peak, 
whereas CoV display the marked seasonality typical of other respiratory viruses, 
with high detection frequencies in the winter months but few or no detections in 
the summer (Schildgen et al. 2008). 
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1.2 RESPIRATORY VIRUSES 
In the following sections we will briefly summarize the main characteristics of the 
analyzed respiratory viruses. 
 1.2.1 Pneumovirus 
The Pneumoviridae family comprises large enveloped negative-sense RNA viruses. This 
taxon was formerly a subfamily within the Paramyxoviridae but was reclassified in 2016 
as a family with two genera, Orthopneumovirus and Metapneumovirus (Rima et al. 
2017). As shown in Table 2, Orthopneumovirus genus is divided into tree species: 
Bovine-, Murine- and Human Orthopneumovirus, Metapneumovirus is divided into 
Avian- and Human Metapneumovirus (Amarasinghe et al. 2018). 
 
Family Pneumoviridae 
Metapneumovirus 
Avian 
metapneumovirus 
Avian metapneumovirus (AMPV) 
Human 
metapneumovirus 
Human metapneumovirus (MPV) 
Orthopneumovirus 
Bovine 
orthopneumovirus 
Bovine respiratory syncytial virus 
(BRSV) 
Human 
orthopneumovirus 
Human respiratory syncytial virus 
A2 (HRSV-A2) 
Human respiratory syncytial virus 
B1 (HRSV-B1) 
Murine 
orthopneumovirus 
Murine pneumonia virus (MPV) 
Table 2. Classification of Pneumoviridae. 
 
Two important respiratory viruses belong to Orthopneumovirus family: Respiratory 
syncytial virus and Human Metapneumovirus (Collins & Karron 2013). 
 
 1.2.2 Respiratory syncytial virus (RSV) 
Respiratory syncytial virus (RSV) belongs to the recently described Human 
Orthopneumovirus genus. RSV was first isolated from nasal secretions of young 
chimpanzees in 1955 and was initially named ‘chimpanzee coryza agent’ (Blount et al. 
1956). A year later, it was also isolated from two child affected by pneumonia and 
bronchiolitis (Chanock et al. 1956). 
Based on serological differences, RSV can be divided in two subtypes (A and B) 
(Anderson et al. 1985), which can both circulate independently and co-circulate 
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(Kneyber et al. 1998). Despite the genomic differences between the two virus subtypes, 
the relationship with the clinical severity is still controversial (Martinello et al. 2002; 
Esposito et al. 2015; Liu et al. 2016; Vandini et al. 2017). The clinical severity of RSV 
infections can vary from mild upper respiratory tract infections to severe bronchiolitis. 
The most common symptoms of RSV-A are: bronchiolitis, dyspnoea, coryza and 
gastrointestinal symptoms, while systemic Flu-like symptoms such as chills, myalgia, 
rash, debility and headache are often associated with RSV-B (Liu et al. 2016). 
RSV is worldwide recognized to be the leading cause of acute lower respiratory tract 
illness in infants and young individuals (Homaira et al. 2016) as well as among elderly 
and immunocompromised patients, usually not as primary infections (Falsey & Walsh 
2005). RSV causes significant paediatric and adult morbidity and mortality, which have 
a significant economic impact on health care systems. In 2005, at least 66.000 children 
less than 5 years old died of RSV infection or of complications directly related to RSV 
infection, the 99% of these cases occurring in developed countries (Nair et al. 2010). 
 
 1.2.3 Human metapneumovirus (MPV) 
This genus consists of viruses infecting human and avian hosts. Members of the 
Human metapneumovirus species are divided into four co-circulating subgroups A1, 
A2, B1 and B2; Subgroup A2 is again subdivided into A2a and A2b (Amarasinghe et 
al. 2018). Metapneumovirus was firstly discovered in 2001, in a 1-month-old child in 
the Netherlands with symptoms like those of RSV infection (van den Hoogen et al. 
2001). This virus causes respiratory infections in children; with high susceptibility rates 
in children less than 2 years old, nearly all children have serologic evidence of infection 
by 5 years of age (Milder & Arnold 2009). Worldwide, MPV infections also occur in 
elderly and immunosuppressed patients. MPV infection in adults normally shows only 
mild flu-like symptoms but in some elders it can cause severe complications such as 
chronic obstructive pulmonary disease (COPD) (van den Hoogen et al. 2001). Studies 
conducted on solid organ and bone marrow transplant patients suggest that infection 
with MPV can cause significant morbidity and mortality in immunocompromised 
hosts (Milder & Arnold 2009). 
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 1.2.4 Human Parainfluenza viruses 1–4 (PIV1 – 4) 
Human Parainfluenza viruses are single-stranded, negative-sense RNA viruses in the 
Paramyxoviridae family and circulate globally as four species. These four species are 
classified into two genera based on their genome, PIV1 and PIV3 as genus 
Respirovirus, and PIV2, PIV4A and PIV4B as genus Rubulavirus (Amarasinghe et al. 
2018). PIV were firstly discovered in the late 1950s from both human and animal 
species with respiratory symptoms (Fukumi Et Al. 1954; Abinanti & Huebner 1959; 
Andrewes et al. 1959). 
PIV are common community-acquired respiratory pathogens, with a worldwide 
distribution leading to both acute upper and lower respiratory infections. PIV 
respiratory infections are generally self-limiting, but infants, children, and 
immunocompromised hosts could instead develop severe diseases (Linster et al. 2018). 
PIV has also been considered an important causative agent of virus-induced asthma 
exacerbations (Holtzman et al. 2004). The bulk of PIV-associated hospitalizations 
among children aged <5 years occurs from ages 0 to 2 years, with a marked increase 
among 1- to 2-year-olds (Abedi et al. 2016). 
Individual PIV species have been related to different clinical outcomes: PIV1 and PIV2 
infection with laryngo-tracheo-bronchitis (croup) and PIV3 with bronchiolitis 
(Henrickson 2003); PIV-4 cause mild clinical symptoms and is the only PIV that does 
not cause croup (Frost et al. 2014). Nevertheless, symptoms observation cannot be 
considered predictive of the PIV species (Schomacker et al. 2012). 
 
 1.2.5 Coronaviruses 
Human Coronavirus are a group of large enveloped RNA viruses under the 
Coronaviridae family. Coronaviridae are divided into four genera (alpha-, beta-, delta-, 
gamma- Coronavirus) able to infect a wide range of hosts. Human Coronavirus are 
229E, NL63 (alpha coronavirus); OC43, HKU1 (beta coronavirus); MERS-CoV (the 
beta coronavirus that causes Middle East Respiratory Syndrome, or MERS) and SARS-
CoV (the beta coronavirus that causes severe acute respiratory syndrome, or SARS) as 
shown in Table 3. 
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Coronaviriniae Genera Strains 
Year of 
Discovery 
Host 
Alpha-coronavirus 
CoV-229E 1966 Bats 
CoV-NL63 2004 
Palm Civets, 
Bats 
Beta-coronavirus 
CoV-OC43 1967 Cattle 
CoV-HKU1 2005 Mice 
SARS-CoV 2003 
Palm Civets, 
Bats 
MERS-CoV 2012 Bats, Camels 
Table 3. Classification of human coronavirus. (Adapted from Lim et al. 2016)  
 
CoVs are associated with respiratory diseases of various severity, from the common 
cold with benign outcomes to life-threatening pneumonia and bronchiolitis, especially 
in elderly, children and immunocompromised patients. SARS and MERS CoVs, that 
have clear zoonotic origins, are highly pathogenic causing atypical pneumonia. CoV-
SARS was first identified in 2003 (Drosten et al. 2003) and, interestingly, clinical course 
and outcome of illness are milder in children younger than 12 years of age than in 
adults (Stockman et al. 2006). 
CoV-MERS was first isolated in a patient from South Arabia (Zaki et al. 2012). Since 
September 2012 to October 2018, WHO notified 2.266 laboratory-confirmed cases of 
infection with MERS-CoV, leading to 804 MERS-CoV-associated deaths. 
 
 1.2.6 Enteroviruses 
Enteroviruses, a genus within Picornaviridae family, are divided into 15 species, three 
RV species (RV-A to RV-C) and 13 EV (non-RV EV) species (EV-A to EV-L). 
Although they are closely related at a genetic level, these viruses have remarkably 
different phenotypic characteristics. 
The tropism of RVs is restricted to upper respiratory airways, except in some rare cases 
of disseminated disease, whereas EVs can infect a wide range of different cells and 
cause a wide range of diseases with both mild and high pathogenicity (Royston & 
Tapparel 2016). 
RVs are single-stranded positive RNA (ssRNA) viruses, firstly isolated in the 1950s 
(Price 1956). RVs are the leading cause of upper respiratory tract infections worldwide 
(Abedi et al. 2016). In fact, RVs are the primary etiological agents of “common cold” 
causing all the significant clinical and economic implications of this disease (Stobart et 
al. 2017). Nevertheless, RVs are frequently cause of relatively minor respiratory 
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symptoms, and have also been described in the context of severe respiratory tract 
infections (Lauinger et al. 2013). Moreover, the relationship between wheezing RV 
infections in early life and development of asthma were reported in high-risk children 
(Makris & Johnston 2018). Three species of human rhinovirus (HRV) are currently 
known: HRV-A, HRV-B, and HRV-C (Palmenberg et al. 2009), which comprise 83 
HRV-A types, 32 HRV-B types, and 55 HRV-C. HRV-A and HRV-C are generally 
associated with more severe disease and more asthma exacerbations than HRV-B (Lee 
et al. 2012). Moreover, HRV-C infections are associated with severe infection in 
children (Makris & Johnston 2018). 
EV can in fact lead to mild symptoms, such as a self-limiting fever, clinical syndromes 
like hand-foot-mouth syndrome but also encephalitis, myocarditis, poliomyelitis, acute 
heart failure and sepsis (Lugo & Krogstad 2016). Notably, EV-D68, have also been 
associated with outbreaks, occasionally resulting in significant morbidity and mortality. 
EV-68 was first identified in 1962 and has been associated with clusters of severe 
respiratory illness (Messacar et al. 2015) and with acute flaccid paralysis and cranial 
nerve dysfunction in children in 2014 (Messacar et al. 2015) and in 2016 (Knoester 
2016). 
 
 1.2.7 Influenza viruses 
Orthomyxoviridae is a family of segmented single stranded negative RNA viruses first 
recovered in 1933 (Smith et al. 1933). Influenza outbreaks have apparently occurred 
since at least the Middle Age, but probably also ancient times (Taubenberger & Kash 
2010). Orthomyxoviridae family is composed by five genera: Influenzavirus A, 
Influenzavirus B, Influenzavirus C, Isavirus, Quaranjavirus and Thogotovirus as 
shown in Table 4. 
Members of Influenza A viruses are pathogens of humans, horses, pigs, mink, seals, 
whales, and fowl causing high pathogenic zoonotic infections. Until 2018, six major 
pandemics had been described, typically named after the presumed location of origin: 
1889: Russian influenza (H2N2); 1900: Old Hong Kong influenza (H3N8); 1918: 
Spanish influenza (H1N1); 1957: Asian influenza (H2N2); 1968: Hong Kong influenza 
(H3N2); 2009: Swine influenza (influenza A [H1N1] pdm09) (De Vlugt et al. 2018). 
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Influenza B only infects humans and seals and is associated with similar symptoms as 
type A, but differently from type A, does not cause pandemics. Influenza C viruses 
infect humans and pigs, rarely causing serious disease. 
The member of the genus Thogotovirus and Quaranjavirus are tick-borne arboviruses 
infecting humans and livestock in Africa, Europe, and Asia. The genus Isavirus is 
named for its type species, infectious salmon anemia virus (Krammer & Palese 2015). 
 
Genera Virus Segments Lenght 
Protei
n 
Host 
Alphainfluenzavirus 
Influenza A virus 
(A/California/07/2009(H1N1)) 
8 13158 
nt 11 
vertebrates, 
human 
Influenza A virus 
(A/Hong Kong/1073/99(H9N2)) 
8 13498 
nt 10 
vertebrates, 
human 
Influenza A virus 
(A/Korea/426/1968(H2N2)) 
8 13460 
nt 12 
vertebrates, 
human 
Influenza A virus 
(A/New York/392/2004(H3N2)) 
8 13627 
nt 12 
vertebrates, 
human 
Influenza A virus 
(A/Puerto Rico/8/1934(H1N1)) 
8 13588 
nt 12 
vertebrates, 
human 
Influenza A virus 
(A/Shanghai/02/2013(H7N9)) 
8 13191 
nt 12 
vertebrates, 
human 
Influenza A virus 
(A/goose/Guangdong/1996(H5N1
)) 
8 13590 
nt 12 
vertebrates, 
human 
Betainfluenzavirus Influenza B virus 
(B/Lee/1940) 
8 14452 
nt 10 
vertebrates, 
human 
Deltainfluenzavirus Influenza D virus 
(D/swine/Oklahoma/1334/2011) 
7 12800 
nt 8 Vertebrates 
Gammainfluenzaviru
s 
Influenza C virus 
(C/Ann Arbor/1/50) 
7 12906 
nt 9 
Vertebrates, 
human 
Isavirus Salmon isavirus 8 12686 
nt 10 Vertebrates 
Quaranjavirus 
Quaranfil quaranjavirus 6 11452 
nt 6 
Vertebrates 
Wellfleet Bay virus 7 11958 
nt 7 
Thogotovirus 
Dhori thogotovirus 6 10616 
nt 6 
vertebrates, 
invertebrate
s, human 
Thogoto thogotovirus 6 10461 
nt 7 
vertebrates, 
invertebrate
s, human 
Table 4. Orthomyxoviridae family 
 
Influenza infections cause characteristic clinical symptoms, like rapid onset of fever, 
malaise, joint pain and cough, but in children atypical presentation are also common, 
such as febrile seizures or gastroenteritis. Other complications can include otitis media, 
myocarditis, dehydration and encephalitis (Esposito et al. 2011). 
Influenza viruses are the most common causes of human respiratory infections and 
one of the major cause of morbidity and mortality. Basing on ECDC Annual 
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Epidemiological Report for 2017-2018 most influenza viruses detected were of type 
B, representing a higher level and a longer period of circulation of influenza B viruses 
compared to previous seasons. 
 
 1.2.8 Adenoviruses 
The first human adenovirus was isolated in 1953 form adenoidal tissue. The 
Adenoviridae family is comprised of relatively large, icosahedral, non-enveloped viruses 
with linear, double-stranded DNA, classified into seven species (A to G), 51 serotypes, 
and over 70 genotypes (Robinson et al. 2013). Due to wing to their genetic 
heterogeneity, ADVs display broad tissue tropism (Ison 2006) and can infect several 
cell types causing different diseases (Table 5) (Ghebremedhin 2014). 
ADV are most commonly associated with pediatric illnesses of the upper respiratory 
tract, including the common cold, but can also cause gastrointestinal, ophthalmologic, 
genitourinary, and neurologic symptoms (Lynch & Kajon 2016). 
 
HAvD 
subgroup 
Serotype Type of infection 
A 12, 18, 31 gastrointestinal, respiratory, urinary 
B, type 1 3, 7, 16, 21 
keratoconjunctivitis, gastrointestinal, 
respiratory, urinary 
B, type 2 11, 14, 34, 35 gastrointestinal, respiratory, urinary 
C 1, 2, 5, 6 
respiratory, gastrointestinal including 
hepatitis, urinary 
D 
8–10, 13, 15, 17, 19, 20, 22–30, 32, 
33, 36–39, 42–49 
keratoconjunctivitis, gastrointestinal 
E 4 keratoconjunctivitis, respiratory 
F 40, 41 gastrointestinal 
G 52 gastrointestinal 
Table 5 Adenoviridae family 
 
ADVs are estimated to cause 2 - 5% of the overall respiratory tract infections and 4 - 
10% of all pneumonias. (Jobran et al. 2018). These viruses mostly cause chronic low-
virulent infection with mild symptoms. In contrast, acute infection is mostly 
characterized by flu-like symptoms but could also lead to severe lower respiratory tract 
infection (Murtagh et al. 2009). 
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 1.2.9 Bocaviruses 
Human bocavirus (HBoV) is a small non-enveloped single-stranded DNA parvovirus 
of about 5300 nucleotides isolated in 2005 at Karolinska University (Allander et al. 
2005) and found worldwide in both respiratory samples, mainly from children with 
acute respiratory infection, and in stool samples from patients with gastroenteritis 
(Bastien et al. 2006). 
HBoV is prevalent worldwide in children with respiratory tract infections (Allander 
2008) both singularly and in coinfection with other respiratory virus (Jartti et al. 2012) 
and it is often detected at low vial loads (Allander 2008). Since that high coinfection 
rate and since HBoV is also detected in respiratory secretions of asymptomatic 
individuals, there is a wide discussion about the real impact of HBoV in respiratory 
pathology (Ligozzi et al. 2017). 
However, single HBoV infection observed several cases of severe pneumonia, asthma 
and/or bronchiolitis both in children and in adults (Kupfer et al. 2006; Vallet et al. 
2009). 
 
1.3 VIRAL CO-INFECTION 
Respiratory viral co-infections, defined as the detection of more than one viral 
pathogen in the same sample, are detected in 15 to 60% of children with an acute 
respiratory tract infection (Liu et al. 2015; Martínez-Roig et al. 2015; Finianos et al. 
2016). 
The most frequently identified viral coinfections are dual RSV-HRV and RSV-HBoV 
infections (Garcia-Garcia et al. 2017) and subjects coinfected with RSV and at least 
another virus (especially RSV-HBoV) seems to had an higher rates of pneumonia 
compared to those with RSV infection alone (Midulla et al. 2010; Goka et al. 2013). 
RSV and FLU-A have been mainly identified among children with single virus 
infection, other viruses, including HBoV, have been mainly reported in children with 
coinfection (Kuypers et al. 2004; Fairchok et al. 2010; Martin et al. 2010). 
The clinical severity of virus coinfection compared to single virus infection remains 
uncertain, although an increased risk of mortality was observed when coinfection are 
detected amongst preschool children (Asner et al. 2014; Asner et al. 2015; Lim et al. 
2016). 
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1.4 POLYOMAVIRUSES 
 1.4.1 Historic overview 
The first polyomavirus infection was described in 1953 by Ludwik Gross, which 
discovered the Mouse polyomavirus (MPyV), a virus able to induce salivary tumours 
in experimentally exposed mice and, when inoculated into newborn mouse, various 
tumours in different site (Gross 1953; Stewart et al. 1957). Hence, the Greek name 
poly for “many” and oma for “tumor”. 
Many studies had followed this first observation, leading to the discovery the first 
primate polyomavirus: SV40 (Sweet & Hilleman 1960; Fenyves & Klein 1963). SV40 
was identified in kidney cells of African green monkey, used to produce polio- and 
adenovirus- vaccines, and like MPyV showed oncogenic activities in mouse (Eddy et 
al. 1962) leading to a big public health concern for individuals receiving SV40 
contaminated vaccines by early 1960’s (Shah & Nathanson 1976). 
The first two polyomaviruses with a natural human tropism, BKHPyV and JCHPyV, 
were independently identified in 1971 in specimens of immunocompromised patients 
(Gardner et al. 1971; Padgett et al. 1971). Early after their first isolation, was proposed 
a role for BKHPyV and JCHPyV in malignant transformation, but the apparent 
ubiquity of BKHPyV and JCHPyV make the association still controversial (Delbue et 
al. 2017; Levican et al. 2018). 
Since then, many Polyomaviruses where isolated from a lot of different host, such as 
mammalian, birds, fish, avian, arthropods (Moens, Calvignac-Spencer, et al. 2017), 
Human Polyomaviruses that will be extensively described in the next paragraphs. 
 
 1.4.2 Polyomavirus classification 
Polyomaviruses where taxonomically classified as a genus in Papovaviridae family until 
2000 when, with the publication of the Seventh report of the international committee 
on taxonomy of virus (ICTV), Papovaviridae family was divided into two families: 
Polyomaviridae and Papillomaviridae. 
Because of the growing quantity and variety of HPyVs the International Committee 
on Taxonomy of Viruses (ICTV) Polyomaviridae Study Group designed a rationale, 
based on the observed distance between large T antigen coding sequences, in order to 
update the taxonomy of the Polyomaviridae family. 
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Last ICTV update (July 2018) divides Polyomavirus into four genera: 
Alphapolyomavirus, Betapolyomavirus, Gammapolyomavirus and Deltapolyomavirus 
that, all together, include more than 80 species. 
Human polyomavirus 5, Human polyomavirus 8, Human polyomavirus 12 and 
Human polyomavirus 13 belong to Alphapolyomavirus genus; Human polyomavirus 
1, Human polyomavirus 2, Human polyomavirus 3 and Human polyomavirus 4 belong 
to Betapolyomavirus genus; Human polyoDNAJ 
mavirus 6, Human polyomavirus 7, Human polyomavirus 10 and Human 
polyomavirus 11 belong to Deltapolyomavirus genus. 
 
 1.4.3 Genome organization 
Polyomaviruses are small, non-enveloped icosahedral viruses of 40-45 nm of diameter 
with circular double-stranded DNA and genomes of approximately 5 kbp.  
Despite the abundance of different HHPyVs, their genomic organizations are similar. 
Viral genome is usually divided into two oppositely oriented transcriptional units, the 
early and late region (EVGR and LVGR) referring to the stage of infection in which 
they are transcribed, separated by a non-coding control region (NNCR) (Gu et al. 
2009). 
EVGR encodes the regulatory large and small T antigens (LTAg and STAg), named 
for their corresponding protein size, that are involved in the coordination of viral 
replication and gene expression (Ajuh et al. 2018), and, for JCHPyV, BKHPyV and 
MCHPyV miRNAs (Seo et al. 2009; Bauman et al. 2011). LTAg is a multifunctional 
protein, with several domains common to all HHPyVs: a DNAJ domain, an origin-
binding domain (OBD), a zinc (Zn)-binding domain, and a helicase/ATPase domain 
(Ahsan 2006). It also binds the tumour suppressor proteins Rb and p53, modulating a 
variety of cell cycle activities critical for tumour formation (De Caprio 2009). 
LVGR encodes the structural VP capsid proteins. The capsid comprises 72 pentamers 
(capsomeres) of VP1, the major structural subunit of the polyomavirus capsid, 
associated with a single molecule of VP2 and, in some HHPyV also VP3, VP4 and a 
small non-structural cytoplasmatic protein called agnoprotein which may have 
transforming activities itself (Gerits & Moens 2012; Baez et al. 2017). 
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NNCR is the less conserved genomic region among HPyV which contain numerous 
transcription factor binding sites (TFBS) and harbours the origin of viral replication 
and bi-directional promoter/enhancer (Barth et al. 2016). 
 
 1.4.4 Human Polyomavirus and disease 
Until 2007, the only two known Human Polyomavirus were BKHPyV and JCHPyV. 
JCHPyV was identified in a patient, John Cunningham (initials JC), with a history of 
Hodgkin's lymphoma and progressive multifocal leukoencephalopathy (PML) (Padgett 
et al. 1971). 
JCHPyV infection is typically acquired in childhood (10-15 years of age) and is 
asymptomatic, resulting in a seroprevalance ranging between 50-90% worldwide by 
adulthood (Egli et al. 2009; Brew et al. 2010). 
JCHPyV in immunosuppressed patients is mostly associated with a demyelinating 
disease of the brain, the progressive multifocal leukoencephalopathy (PML) (Tan & 
Koralnik 2010; Saribas et al. 2010; Brew et al. 2010). 
JCHPyV reactivation is also implicated in pathogenesis of colorectal cancer (Goel et 
al. 2006; Jung et al. 2008; Selgrad et al. 2008) and with Multiple Sclerosis (Khalili et al. 
2007). 
During the same year, Brennan-Krohn virus (BKHPyV) was isolated from the urine 
of a Sudanese kidney transplanted patient with ureteric stenosis (Gardner et al. 1971). 
BKHPyV virus primary infection often occurs in childhood (3 - 4 years of age) and is 
usually first asymptomatic. Consequently, seropositivity across the adult population is 
as high as approximately 90% (Egli et al. 2009), with intermittent reactivation 
throughout life.  
BKHPyV reactivation is associated with complication in immunocompromised host 
in particular with nephropathy (BKVAN), including haemorrhagic and non-
haemorrhagic cystis, haematuria, urethral stenosis and interstitial nephritis. Less 
commonly, BKHPyV infection can lead to liver disease, pulmonary manifestation such 
as pneumonitis and ophthalmological and neurological complication wit retinitis and 
meningoenphalitis (Rajpoot et al. 2007; Dropulic & Jones 2008). 
Since 1971, 11 new species of human polyomaviruses were identified. In 2007 two 
polyomaviruses have been firstly identified, by high-throughput sequencing of DNA 
from nasopharyngeal samples, KI polyomavirus (KIHPyV) (Tobias Allander et al. 
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2007) and WU polyomavirus (WUHPyV) (Anne M Gaynor et al. 2007), that received 
their name by the institutions of their first discovery (Karolinska Institute, Stockholm, 
Sweden and Washington University St. Louis, USA). Characteristics of KIHPyV and 
WUHPyV will be extensively discussed in next chapter. 
In 2009, two new polyomaviruses were found in association with human diseases: 
Merkel cell polyomavirus (MCHPyV) and TS polyomavirus (TSHPyV). 
MCHPyV was detected from the tissues of patients with Merkel cell carcinoma (MCC) 
(Feng et al. 2008) and then strongly associated to this a rare, aggressive, neuro-
endocrine tumour mostly observed in elderly or immunocompromised patients (Arora 
et al. 2012; Richards et al. 2015). 
It also has been suggested a common nature between MCC and chronic lymphocytic 
leukaemia (CLL) (J. Kaae et al. 2010; Koljonen et al. 2010; Jeanette Kaae et al. 2010), 
but this second association is still controversial (Pancaldi et al. 2011). 
TS polyomavirus (TSHPyV) was identified in association with Trichodysplasia 
Spinulosa (van der Meijden et al. 2010). Trichodysplasia spinulosa is a rare skin disease 
exclusively found in severely immunocompromised patients, especially solid organ 
transplant recipients (Elaba et al. 2012; Bagasi et al. 2018). 
Many other Polyomaviruses were then discovered, but with low or no association with 
disease or malignant transformation. Human polyomavirus 6 (HPyV6) and human 
polyomavirus 7 (HPyV7) where first identified in 2010 (Schowalter et al. 2010), and 
recently HPyV7, but not HPyV6, has been linked to a pruritic skin eruption in 
immunosuppressed patients (Nguyen et al. 2017). 
Also, for human polyomavirus 9 (HPyV9) (Scuda et al. 2011), human polyomavirus 10 
(HPyV10) (Yu et al. 2012), human polyomavirus 11 (HPyV11) (Lim et al. 2013), human 
polyomavirus 12 (HPyV12) (Mishra et al. 2014) and human polyomavirus 13 
(HPyV13) (Mishra et al. 2014) pathogenic role is mostly still unclear, even if a 
correlation with diarrhea was hypothesized (Barth et al. 2016; Vanchiere et al. 2016). 
HPyV9 was originally isolated from a kidney transplant recipient HHPyV9 as an 
emerging infection in immunosuppressed kidney transplanted patients, causing both 
systemic and skin infection. (Scuda et al. 2011) Whether HHPyV9 is pathogenic in 
immunocompromised patients, alone or in concert with the well-known pathogen 
BKHPyV, the association deserves further study (Nguyen et al. 2017). 
In 2017 a new putative member of the family, the Human Polyomavirus 14 or Lyon 
 23 
 
IARC PyV (LIPyV), has been described, awaiting further confirmation as a member 
of HPyV (Gheit et al. 2017). 
 
1.5 KIHPYV AND WUHPYV 
Since first identification of KIHPyV and WUHPyV, viral sequences where confirmed 
in respiratory specimens worldwide, leading a possible association between upper 
and/or lower respiratory tract infections and the presence of these two viruses (Anne 
M. Gaynor et al. 2007; Wattier et al. 2008). 
In adult population these two viruses seem to be more frequently associated to upper 
tract infection, else in the youngest one to lower tract respiratory infection (Abedi 
Kiasari et al. 2008). 
Various other biological specimens and tissue have been screened for the presence of 
KIHPyV and WUHPyV. 
Recently, a Hungarian study described the presences of both KIHPyV and WUHPyV 
in tonsils and adenoids and evidence of detection of WUHPyV into the middle ear 
were (Csoma et al. 2018). 
Same authors also reported the presence of KIHPyV in respiratory, blood and urine 
samples collected from renal transplant patients and presence of WUHPyV in in 
respiratory and blood samples (Csoma et al. 2015) but not in in kidney and urinary 
bladder tumor tissue samples (Csoma et al. 2016). 
No WUHPyV was detected in either respiratory samples, blood or urine of pregnant 
and non-pregnant woman; the same study reported KIHPyV DNA detection in 2% 
of non-pregnant woman (Csoma et al. 2012). 
 In another study, involving fecal, urine, blood, cerebrospinal fluid and respiratory 
samples, the two viruses were primarily founded in NPAs, BALs, and feces of young 
and immunocompromised patients, but not in urine and in CSF (Bialasiewicz et al. 
2009). 
Presence of KIHPyV and WUHPyV in the CSF is still controversial. No WUHPyV or 
KIHPyV DNA has been reported analysing the CSF of patients with or without PML 
(Bialasiewicz et al. 2009; Giraud et al. 2009; Dang et al. 2011), but Barzon and 
colleagues reported presence of the two viruses in HIV-1 positive patients with and 
without progressive multifocal leukoencephalopathy (Barzon, et al. 2009). These 
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different findings are probably due to the differences in patients enrolled for the 
studies and to the lack of standardized methods for WUHPyV and KIHPyV detection. 
Also, other authors investigated presence of the two viruses in HIV-positive patients 
(Babakir-Mina, et al. 2009; Bialasiewicz et al. 2009; Tatiana F Robaina et al. 2013; 
Nunes et al. 2014), but no correlation between the presence of the two viruses and 
HIV-1 viral load or CD4+ count was found (Mourez et al. 2009). 
Other studies reported the detection of the two polyomaviruses in gastrointestinal tract 
and stool of patients with clinical symptoms, often in coinfection with another 
pathogen virus (Babakir-Mina, Ciccozzi, Alteri, et al. 2009; Ren et al. 2009). These data, 
although are not enough for a causal association between these viruses and 
gastrointestinal disease, could suggest a trend of association with diarrhea and 
vomiting, proposing oro-fecal as transmission route of these viruses (Babakir-Mina et 
al. 2013). 
WUHPyV and KIHPyV DNAs were also detected in saliva samples of healthy 
volunteers, posing the hypotheses that saliva may be a route for transmission, and that 
the oral cavity could be a site of virus replication as for BKHPyV (Tatiana F. Robaina 
et al. 2013). 
Seroepidemiological studies showed that infection by these viruses is widespread in the 
human population: WUHPyV and KIHPyV positive samples were found in Australia 
(Anne M Gaynor et al. 2007; Bialasiewicz et al. 2009); France (Touinssi et al. 2016); 
South Corea (Han et al. 2007); Germany (Neske et al. 2010); Philippine (Rao et al. 
2016); Brazil (Pena et al. 2018); Italy (Babakir-Mina et al. 2013) etcetera; with high 
detection rate in adults population (Nguyen et al. 2009) suggesting that infection occurs 
early in childhood (Moens, Krumbholz, et al. 2017). 
As for other polyomaviruses, reactivation of the two viruses seems to be related to 
immunosuppression, including stem cell transplanted (Sharp et al. 2009; Kuypers et al. 
2012) and, as previously mentioned, HIV-1 positive patients. 
 In patients with respiratory symptoms, the prevalence of KIHPyV varied from 0, 5 to 
7%, else WUHPyV DNA genome is even detected more commonly, in fact the 
prevalence varied from 3 to 9% (Abedi Kiasari et al. 2008; van der Zalm et al. 2008; 
Essa et al. 2015; Gozalo-Margüello et al. 2015; Zhu et al. 2017a; Essa et al. 2017; Zhu 
et al. 2017b). 
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Detection of KIHPyV and WUHPyV genome in respiratory samples is often related 
to a high co-infection rate with other major respiratory diseases such as RSV, PIV, 
ADV, HRV and Flu Viruses (Debiaggi et al. 2012; Moens et al. 2013) making hard the 
correlation between viral DNA presence and disease. 
Little is known about the oncogenicity of KIHPyV and WUHPyV (Prado et al. 2018). 
KIHPyV detection has been reported in lung cancer tissue, but the meaning of this 
finding remains unclear (Teramoto et al. 2011). 
No KIHPyV or WUHPyV was detected in neuroendocrine tumor (Duncavage et al. 
2009), urinary bladder tumors (Csoma et al. 2016) and melanoma (Giraud et al. 2008). 
 
 1.5.1 Genomic differences among WUHPyV, KIHPyV and 
 other  HHPyVs 
Although the similar genomic structure of the entire human described human 
polyomaviruses, there are significant sequence differences between them that have 
affected at least on their life cycle and host cell tropism (DeCaprio & Garcea 2013). 
KIHPyV (5040 bp) (T. Allander et al. 2007) and WUHPyV (5229 bp) (Anne M. 
Gaynor et al. 2007) genome sizes are within the range of other polyomaviruses. The 
two genomes, shown in Figure 1, have the highest sequence identity between each 
other, but results quite divergent from other polyomaviruses (Rima et al. 2017). 
Interestingly, high divergence occurs in LTAg critical domains, in p53- and in DNA-
binding sites of T-antigens: KIHPyV and WUHPyV show high aminoacidic identity 
both in T-antigen (70%) and P53/DNA-binding (68%), else, if compared with 
JCHPyV and BKHPyV, show high divergences (from 30 to 50%). 
Hyper variability of LTag binding site affects viral transcription, replication and 
cytopathology in cell cultures and is also related to different ability to bind p53 and 
consequently to the different oncogenic value of HPyV. 
In addition, KIHPyV and WUHPyV show a high homology rate between themselves 
(68%) and a higher difference with other HPyV (almost 30% of homology) (Johnson 
2010) in VP1 protein sequences. 
This VP1 homology comparison may reflect differences in tissue tropisms among the 
different classes of polyomaviruses (Moens, Krumbholz, et al. 2017). 
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Moreover, unlike the other HPyV, BKPyV and JCHPyV encode for the agnoprotein, 
which has a critical role in the regulation of viral gene expression and replication, in 
the modulation cell cycle progression and in DNA repair (Khalili et al. 2005). 
In addition, viral encoded miRNAs, which have the ability to negatively regulate the 
expression of viral gene expression, have been found to be encoded by BKHPyV, 
JCHPyV and MCHPyV (Chen et al. 2015) but not by KIHPyV and WUHPyV. 
 
 
 
 
 
 
 
 
 
Figure1. KIHPyV and WUHPyV, from (T. Allander et al. 2007) and (Anne M Gaynor et al. 2007). 
 
 1.5.2 KIHPyV and WUHPyV diagnosis and treatment 
KIHPyV and WUHPyV were discovered by Random PCR amplification, large-scale 
sequencing, library construction and bioinformatics analysis (Allander et al. 2005). 
Since then, various detection methods for these two viruses have been developed, 
mostly molecular ones. In fact, almost all the previously described KIHPyV and 
WUHPyV-DNA detection methods are based on PCR amplification. Differences in 
sensibility and specificity of the assays can be ascribed to the choice of target region 
and to the choice of primer and probe sequences (Bialasiewicz et al., 2007a, Bergallo 
et al., 2009): primers/probes designed in the VP1 region give a higher detection rate 
than the primers/probes designed in the regulatory or sTAG (Bergallo et al., 2009). 
In addition, several enzyme-linked immunosorbent assays (ELISA) tests had been 
developed for human VP1 antibodies, reporting the high serological prevalence of the 
two viruses (Nguyen et al. 2009). 
Anyway, based on the currently available data, KIHPyV and WUHPyV routine testing 
of respiratory samples from immunocompromised have been suggested (Kuypers et 
al. 2012). 
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As the hypothesis that these two viruses do play an etiological role in childhood 
respiratory-tract disease is still controversial, no treatments regimen for KIHPyV and 
WUHPyV have still been implemented. 
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2. AIMS OF THE STUDY 
Respiratory infections are one of the major causes of morbidity and mortality. These 
diseases affect the respiratory tree and cause a spectrum of diseases ranging from 
rhinitis to pneumonia. In particular, the groups of patients more susceptible to these 
diseases are children, patients with immunodeficiency and the elderly.  
If we consider the number of cases per year and the pathogenic viruses that cause these 
infections, we can observe how high the clinical and social impact of viral respiratory 
infections is. 
Cell cultures were the first diagnostic methods employed for the detection of 
respiratory viruses. This approach was overcome by the advent of molecular methods.  
Several molecular formats are currently in use for the identification of many respiratory 
viruses, in particular Multiplex PCR systems that lead to the simultaneous amplification 
of selected viral panels. 
Despite their undoubted usefulness, these methods do not completely satisfy the need 
for diagnosis of newly characterized viruses, such as the recently discovered KIHPyV 
and WUHPyV. These two viruses have been associated with respiratory diseases, even 
though their real clinical significance is still debated. 
In order to better investigate the role of these viruses, their epidemiology and 
diagnosis, we set up a molecular method for the detection of KIHPyV and WUHPyV 
infections that could be added to the multiplex PCR methods used in the screening 
and diagnosis of viral respiratory infections. To do so, we developed a specific, 
TaqMan–based real-time PCR diagnostic method for simultaneous detection of 
KIHPyV and WUHPyV in respiratory samples. To validate this method, we applied it 
on the NPA collected between October 2016 and October 2018 in the hospital of 
Verona from a cohort of pediatric patients with respiratory symptoms, previously 
analyzed by Multiplex PCR for the presence of 16 major respiratory viruses. 
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3. MATERIAL AND METHODS 
3.1. CLINICAL SAMPLES 
Nasopharyngeal aspirate (NPA) samples were collected from 831 hospitalized children 
(age <5 years) with symptomatic respiratory tract infections. These specimens were 
collected between October 2016 and October 2018 at Verona Hospital. 
NPA swabs were transported to laboratory in sterile transport medium (Universal 
Transport Medium, Copan Diagnostics, Murrieta, CA, USA). 
All samples were stored at -70°C prior to processing. 
These samples were analyzed for respiratory virus with AllplexTM respiratory panel 
assay kit (Seegene, Seoul, South Korea) and retrospectively with home-made TaqMan-
based duplex real-time PCR for the detection of KIHPyV and WUHPyV genomes. 
 
3.2 NUCLEIC ACID EXTRACTION AND PURIFICATION 
Nucleic acids extraction from samples was carried out with a Microlab Nimbus 
apparatus (Hamilton Robotics, Reno, NV, USA). The procedure is based on reversible 
adsorption of nucleic acid to paramagnetic beads under appropriate buffer conditions. 
Lysis of NPA samples is performed with SDS/Proteinase K solution (LB) and Binding 
Buffer (BB) is added to adjust binding condition under which nucleic acids can bind 
the paramagnetic beads. After magnetic separation, the paramagnetic beads are washed 
with four Washing Buffer (WB, WB1, WB2, and WB3) to remove salt, contaminants 
and PCR inhibitors. Finally, purified nucleic acid can be eluted with low salt Elution 
Buffer EB (10mM Tris-EDTA pH 7.5). 
Briefly, nucleic acids were extracted adding 350 μL of NPA to 340 μL of LB, 25 μL of 
proteinase K and 10 μL of internal control provided in the extraction kit. This mixture 
was incubated at 56°C for 5 min with 25 μL of silica and 1160 μL of BB. When all the 
magnetic beads have been attracted to the magnets of magnetic separator supernatant 
is removed. Magnetic beads are than washed with 600 μL of WB1, separated with 
magnetic separator, supernatant is discarding, and the same operation is performed 
with 600 μL of WB2. Two more washing steps are performed with 600 μL of WB 
(82% Ethanol) and 900 μL of WB3 (water-based). Nucleic acid was then incubated for 
3 minutes at 56 C with 100 μL of EB recovered in microtubes. The purified nucleic 
acids were stored at -70°C until use. 
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3.3 AllplexTM respiratory panel assay kit detection procedure 
The samples were analyzed for respiratory virus with AllplexTM respiratory panel assay 
kit (Seegene, Seoul, South Korea). AllplexTM technology is based on MuDT™ 
(Multiple Detection Temperatures) Technology, which enables the detection of 
multiple target in a single fluorescence channel. MuDT™ algorithm comprises of 
DPO™ and TOCE™ enable assay for the detection of fluorescence intensity and 
multiple temperature. 
DPO™ technology provide specific multiplex amplification because of a priming 
structure that is composed of two priming regions: a 5′ conserved (longer, 18–25 nt) 
region and a 3′ specific (shorter, 6–12 nt) region connected by a poly-deoxyinosine 
stretch that bridges the two segment pairs. The poly-deoxyinosine linker would form 
a bubble- like structure and separate a single DPO™ primer into two functional 
regions that, because of the different size, leads to different annealing temperature. As 
5′ portion is approximately two times longer than 3′ has a higher melting temperature 
and will preferentially bind the target DNA first during PCR acting as a “stabilizer” 
and initiating the annealing to the target sequence. In contrast, the short 3'-segment 
cannot bind target DNA by itself at standard PCR annealing temperatures so act as a 
"Determiner" specificity, because his binding is required for the elongation of DPO™ 
primer. 
DPO™ primer are, together with Pitcher and Catcher, a key component of TOCE™ 
technology, for establishing arbitrary melting temperature to identify different target. 
Pitcher is a tagging oligonucleotide composed by a targeting portion, which hybridize 
specifically the target region, and a tagging portion, designed not to bind target region. 
Catcher is a fluorescently a dual-labeled and single-stranded artificial template with a 
portion complementary to the Pitcher’s tagging region. During PCR extension, the 
unbound 5’ portion (tagging portion) of the Pitcher oligonucleotide is cleaved off by 
Taq DNA polymerase exonuclease activity. Tagging portion is than released and 
anneals to the complementary portion of the Catcher. Extension of the Tagging 
portion on the Catcher template results in a Duplex Catcher causing an increasing of 
the physical distance of the fluorescent reporter from the quencher, thereby generating 
signal that is directly correlated to the quantity of the target DNA. 
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Since the Catcher is constructed to have a designated Tm, this expected specific Tm 
value can be controlled by adjusting length and composition of the Catcher and will 
not be affected from variations in the target sequence. 
In addition, Catchers with unique Tm profiles can be detected in the same reaction 
and in the same color channel, significantly increasing the number of targets that can 
be simultaneously detected in the conventional four-channel Real-Time thermocycler. 
 
Figure 2. A representative example of Pitcher-Catcher designs to differentiate between three unique 
melting curves for three unique targets in a single channel, with Tm values ranging from 
60°C, 65°C, and 70°C. 
 Modified from http://seegene.com/neo/en/introduction/core_toce.php 
 
Implementing DPO™ and TOCE™, MuDT™ technology can detect multiple targets 
in a single fluorescence channel using Detection Temperature and without requiring 
the melting curve analysis. Detection temperatures are defined as the temperature 
where unquenched fluorescence signal is measured at each cycle during Real-time PCR 
reaction. As with TOCE technology different target can be designed with different Tm 
(as shown in Figure 2) relatively different Detecting Temperature can be selected for 
the collection of fluorescent signals. At the lower Detection Temperature signal of all 
the targets will overlap, whereas at higher Detection Temperature only signal of the 
target with the higher temperature will be detected. To discriminate between 
overlapping signal and find the real Ct value of all the single target MuDT™ algorithm 
exactly subtract fluorescence signal from the target designed with the lower Detection 
Temperature from other florescence signal collected at the same temperature. 
MuDT™ algorithm than converts subtracted fluorescence signal Δ RFU (Relative 
fluorescence Units) into a Ct enabling the measurement of target Ct values by analyzing 
fluorescence signals collected at different detection temperatures. 
AllplexTM respiratory panel assay kit is able to detect two DNA viruses and fourteen 
RNA viruses including human adenovirus (ADV) and human Bocavirus (HBoV) for 
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DNA viruses, Influenza A and B viruses (FluA, FluB), human parainfluenza viruses 
1/2/3/4 (PIV1/2/3/4), human rhinovirus A/B/C (HRV A/B/C) without subtype it, 
human respiratory syncytial viruses A and B (RSV A, RSV B), human bocaviruses 
1/2/3/4 (HBoV1/2/3/4) without subtype it , human coronaviruses 229E, NL63 and 
OC43 (CoV229E, CoVNL63, CoVOC43), human metapneumovirus (MPV), and 
human enterovirus (HEV) for RNA viruses. Three detection panels compose 
AllplexTM respiratory panel assay kit:  panel 1 includes the Flu A virus (subtypes H1, 
H1N1-pdm09, and H3), Flu B virus, RSV A and RSV B; panel 2 includes ADV, MPV, 
HEV and PIV1/2/3/4; panel 3 includes HBoV, CoVOC43, CoV229E, CoVNL63, 
and HRV. 
Real-time PCR reaction mixture was prepared as follows: the extracted nucleic acid (8 
μl), 17 μl of one -step RT -PCR premix.  
TOCE™ assay was performed using CFX96 real-time PCR detection system (Bio-Rad 
Laboratories, Richmond, VA, USA) as follows: 
 initial reverse transcription step at 50°C for 20 min 
 1 cycle of initial denaturation at 95°C for 15 min 
 45 cycles of denaturation at 95°C for 10 s, annealing at 60°C for 1 min, and 
extension at 72°C for 10 s (fluorescence detection at 60 °C and 72 °C) 
The validation of DNA extraction and amplification was performed using an internal 
control (IC) and negative and positive controls. 
Bacteriophage MS2 was added as an IC to clinical specimens before nucleic acid 
extraction and was incorporated into the product as an exogenous whole process 
control, in order to monitor all the analyses, from nucleic acid isolation to result 
interpretation. The IC was co‐amplified with the target nucleic acids within the clinical 
specimens a positive test result was defined as a well-defined exponential fluorescence 
curve that crossed the CT at a value of <42 for individual targets. 
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3.4 DUPLEX REAL-TIME PCR 
The amplification was carried out in a Bio-Rad CFX96 real-time PCR system. 
To perform simultaneous amplification and quantification of two target sequences in 
a single qPCR assay two reporters are required, in order to distinguish each reaction. 
Reporter fluorophores had to be chosen with minimally overlapping emission spectra, 
compatible with the excitation and emission filters of your real-time PCR detection 
system. We decide to use FAM™ (emission spectra 517 nm) and VIC® (emission 
spectra 551 nm) dye-labeled TaqMan® probes. 
The analysis of results was determined by real-time CFX Manager Software version 
3.1 (BioRad Laboratories). All standard dilutions, controls and samples from patients 
were run in duplicate and the average value of the copy number was employed to 
quantify KIHPyV or WUHPyV genome contents. 
Exact values were employed for calculations, excluding the decimal values. The 
efficiency of the assay should be 90–105%, the R2 of the standard curve should be 
>0.980 (or r > –10.990). 
 
 3.4.1 Bioinformatics analysis 
BLAST (http://www.ncbi.nlm.nih.gov/BLAST) searches were performed to check 
for the presence of known sequence variations and to avoid any cross homology both 
to other types of polyomaviruses and to human sequences. 
Multiple Sequence alignment (MSA) was performed using Clustal Omega 
https://www.ebi.ac.uk/Tools/msa/clustalo, an offline multiple sequence alignment 
program. Phylogenetic tree based on the Neighbour Joining method was constructed 
using the alignment scores with ClustalW2 Simple Phylogeny program 
https://www.ebi.ac.uk/Tools/phylogeny/simple_phylogeny/ and with the graphical 
editor TreeDyn http://www.treedyn.org/. 
Mfold (http://unafold.rna.albany.edu/?q=mfold) was used to predict whether the 
amplicon would form any secondary structure at the annealing temperature. 
Primers applied were designed by using: 
Primer3 (http://primer3.ut.ee/) 
and analyzed using: 
OligoAnalyzer by IDT (http://eu.idtdna.com/calc/Analyzer/application/oligoanalyzer). 
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 3.4.2 Target sequence selection 
Phylogenetic comparison of sequences for each viral protein clearly groups KIHPyV 
and WUHPyV together in a new branch (Dalianis, 2009); the two viruses show a high 
similarity in the high conserved VP1 major capsid protein region. (Delianis, 2013). 
To analyse VP1 target region of KIHPyV and WUHPyV we perform Multiple 
Sequence Alignment and we generate phylogenetic tree based on the Neighbour 
Joining method using the ClustalW2 Simple Phylogeny program and TreeDyn, a 
graphical editor for binary trees (shown in Figure 3) 
 
 
Figure 3. Phylogenetic tree of known Human Polyomavirus. 
 
We perform BLAST searches to check for the presence of known sequence variations 
and to avoid any cross homology to both other types of polyomaviruses and human 
sequences. In order to confirm the high degree of similarity of KIHPyV and WUHPyV 
candidate target region VP1 against another human polyomavirus (Table 6) we 
performed an MSA using Clustal Omega. 
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Name 
VP1 genome 
position 
Reference 
Sequence 
KIHPyV 1498 to 2634 NC_009238.1 
WUHPyV 1670 to 2279 NC_009539.1 
BK polyomavirus 1564 to 2652 NC_001538.1 
JC polyomavirus 1469 to 2533 NC_001699.1 
Merkel cell polyomavirus 1156 to 2427 NC_010277.2 
Human polyomavirus 6 1287 to 2450 NC_014406.1 
Human polyomavirus 7 1305 to 2447 NC_014407.1 
Trichodysplasia spinulosa-associated polyomavirus 1311 to 2438 NC_014361.1 
Human polyomavirus 9 1443 to 2558 NC_015150.1 
MW polyomavirus 1353 to 2564 NC_018102.1 
STL polyomavirus 1242 to 2447 NC_020106.1 
Human polyomavirus 12 1405 to 2499 NC_020890.1 
New Jersey polyomavirus 1062 to 2531 NC_024118.1 
Table 6. Polyomavirus reference strains. 
 
After MSA, we generate phylogenetic tree based on the Neighbour Joining method 
using the ClustalW2 Simple Phylogeny program and TreeDyn, a graphical editor for 
binary trees. 
MSA was also performed to confirm the high degree of similarity between all KIHPyV 
and WUHPyV deposited strains. 
Target regions to amplify were chosen following these criteria: 
 Select a short region (in order to obtain a 75–150 bp product) Efficiency of 
amplification is higher for short PCR products than longer ones, but the PCR 
product should be at least 75 bp long to easily distinguish it from primer-dimer 
 Avoid regions that have secondary structures 
 Avoid regions with long (>4) repeats of single bases 
 Choose a region that has a GC content of 50–60% 
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 3.4.3 Primers and probe design 
Specific primers were selected from conserved regions corresponding to the major 
capsid protein VP1 major capsid protein of KIHPyV (from nucleotide 1498 to 2634, 
378 aa) NCBI Reference Sequence: NC_009238.1 and WUHPyV (from nucleotide 
1670 to 2779, 369 aa) NCBI Reference Sequence: NC_009539.1 genome. 
Primers were selected using the following parameters: 
 Melting temperature (Tm) between 58◦C and 62◦C, Tm values is calculated by 
using the nearest-neighbor method 
 Less than 2◦C difference in Tm between the two primers 
 (G+C) content between 40-60%, avoiding repeats of Gs or Cs longer than 3 
bases 
 Length between 18 - 22 bp 
 Avoid the formation of secondary structure of the primers and prevent primer 
dimer formation, especially at 3’ 
Probes were designed using Primer3 and selected within the target, possibly to anneal 
to the strand that has more Gs than Cs and using the following parameters: 
 Tm 5–10°C higher than that of the primers 
 Length <30 nucleotides 
 No G at its 5' end because this could quench the fluorescence signal even after 
hydrolysis 
In order to perform a duplex Real-Time PCR, all primers and probes will be present 
in one reaction, so we design it following next parameters: 
 All primers have approximately the same Tm 
 All probes to have approximately the same Tm (~5–10°C higher than that of 
the primers) 
 The different primer and probe sets do not exhibit complementarity to one 
another 
BLAST searches were performed to test the specificity of the probes and primer pairs. 
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 3.4.4 Absolute quantification 
Absolute quantification was performed with standard curve method. Standard curve 
method measures expression through comparison with serial dilutions of known copy 
number of a selected sequence in a separate PCR assay. Synthetic oligonucleotides 
(BMR Genomics, Padua, Italy) were designed from nucleotide 2437 to 2518 of 
KIHPyV NCBI Reference Sequence: NC_009238.1 (82 bp) and from nucleotide 2587 
to 2665 of WUHPyV NCBI Reference Sequence: NC_009539.1 (78 bp) (Yang et al. 
2012). The oligonucleotides were quantified by spectrophotometry. We used scalar 
dilutions of synthetic positive control, from 5x106 to 5x101 copies/mL as reference 
curves. 
 
 3.4.5 TaqMan-based duplex real-time PCR assay for 
  KIHPyV and WUHPyV detection 
TaqMan-based real-time quantitative PCR was carried out in a total reaction volume 
of 50μL consisting of 25μL of TaqMan Universal Master Mix (Applied Biosystems, 
CA, USA), 0.5 µM of each KIHPyV and WUHPyV specific primers, 0.25 μM of 
KIHPyV and WUHPyV specific probes, 10μL of DNA extracted either from clinical 
samples or scalar dilutions of synthetic positive control (from 5x106 to 5x101 
copies/mL) and 12.5μL of double-distilled water. 
Quantitative analysis was determined by interpolating the Ct value of sample on 
external reference curve obtained with serial concentrations of KIHPyV or WUHPyV 
synthetic DNA. 
 
 3.4.6 Validation of TaqMan-based duplex real-time PCR 
  Assay for KIHPyV and WUHPyV detection 
The development and validation of lab-developed assays (LDTs) are strictly regulated 
by the Clinical Laboratory Improvement Amendments (CLIA). Performance 
specifications of our LDT test are settled for the following characteristics: analytical 
sensitivity (limit of detection), precision (replication study) and analytical specificity 
(cross-reactivity and interference studies) as reviewed from Eileen M. Burd (Burd 
2010). 
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  3.4.6.1 Probit analysis 
Probit analysis is a type of regression analysis widely used to empirically determining 
the LOD of an assay when the number of replicated tested at each concentration is 
low. We used 10 replicates at each concentration, even if it is not necessary to have the 
same number of replicates for each concentration. Probit analysis transforms the 
concentration-response curve to a straight line that can then be analyzed by regression 
using, in our case, maximum likelihood. Endpoint used to compare different 
concentration is C95, which represents the concentration at which 95% of the samples 
containing that target concentration are detected as positive. 
Data needed for the construction of a graph of the Probit values versus the log of the 
concentration’s analysis are: 
 list of the concentrations tested, that will be transformed in log10 
 the number of positive samples per each concentration, that will be than 
converted to Probit values 
 the total number of samples tested per concentration 
The graph is than constructed and line of regression is fit. The C95 is determined as 
the inverse log of the concentration associated to Probit value of 9.50. 
 
  3.4.6.2 Precision of the assay 
In order to assess the repeatability (or within run imprecision) defined as the “the 
smallest measure of precision and involving measurements carried out under the same 
conditions” (International Organization for Standardization. 2006. Statistics—
vocabulary and symbols, part 1. Probability and general statistical terms. ISO 3534-1. 
International Organization for Standardization, Geneva, Switzerland. International 
Organization for Standardization. 1993. International vocabulary of basic and general 
terms in metrology. International Organization for Standardization, Geneva, 
Switzerland) of the assay, we performed our assay on serial dilutions of known 
concentration of KIHPyV or WUHPyV synthetic DNA in triplicate. We use % 
Coefficient of variation (CV %) as indicator of precision, determined as the ratio of 
the standard deviation to the mean multiplied by 100 and represents the extent of 
variability of an assay. 
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  3.4.6.3 Repeatability of the assay 
The repeatability of the Duplex real-time RT-PCR assays was evaluated by determining 
the intra- and inter-assay coefficient of variation (CV). A 10-fold serial dilution of 
synthetic positive control, from 5x106 to 5x101 copies/mL was tested in triplicate in 
two independent sessions. 
Intra-assay CV% was determined for identical sample triplicates as the ratio of average 
of each replicate’s Ct standard deviation (SD) to the average of each replicate’s Ct 
average x 100. 
Inter-assay CV% was determined for identical sample triplicates analyzed in three-
separated experiment, performed in three different days as the ratio of SD of the Ct 
averages for each replicate to the average of the averages for each replicate x100. 
(Duplex Real-Time RT-PCR Assays for the Detection and Typing of Epizootic 
Hemorrhagic Disease Virus) 
 
  3.4.6.4 Analytical sensitivity 
“Analytical sensitivity” is an inherent characteristic of an assay, defined as the capability 
of an assay to detect the lowest concentration of a given substance in a biological 
specimen (Saah and Hoover, 1997) and is often referred to as the “limit of detection” 
(LOD). LOD of our assay is expressed as a concentration (copies/ml) considering that 
the lower is the value the greater is the analytical sensitivity of the assay. As our assay 
is a Duplex assay LOD had been calculated both individually for each target (KIHPyV 
and WUHPyV) tested and using combinations of KIHPyV and WUHPyV synthetic 
DNA at high (106 copies/ml) and low (103 copies/ml) concentrations. Combination 
of high and low concentrations of target show that a high concentration target will not 
outcompete a low-concentration target present in the specimen and to demonstrate 
that there are no cross-reactivity or interference between the pathogen and the 
different primers/probes. 
LOD can be empirically determined by testing serial dilutions of known concentration 
of the target (CLSI/NCCLS, 2004) using Probit, defined as “unit of measurement of 
statistical probability based on deviations from the mean of a normal distribution”. 
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  3.4.6.5 Analytical specificity 
“Analytical specificity” refers to the capability of an assay to detect the target of 
interest, avoiding “false-positive” results and any cross-reactivity that can be caused, 
in our case, by potentially interfering nucleic acids. As in our assay two target are 
quantified by the same method, each one can also be considered as a possible 
interference for the others. Assay specificity was investigated by TaqMan-based duplex 
real-time PCR amplification of sample negative for both KIHPyV and WUHPyV. In 
addition, different both positive and negative samples for different respiratory viruses 
including Flu A virus, Flu B virus, RSV A and RSV B, ADV, MPV, HEV, PIV, HBoV, 
CoV and HRV and negative for KIHPyV and WUHPyV were targeted for TaqMan-
based duplex real-time PCR. 
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4. RESULTS 
 
4.1 RETROSPECTIVE ANALYSIS OF 831 RESPIRATORY SAMPLES 
We have collected 831 nasopharyngeal aspirate specimens from paediatric patients (age 
<5 years) with respiratory symptoms followed at the Hospital of Verona between 
October 2016 and October 2018.  
These samples were analysed with a multiplex PCR represented by Allplex™ 
respiratory panel assay kit. This assay can determine the 16 major viruses associated to 
respiratory infection through three specific panels. 
This multiplex amplification technique detected specific genome sequences of one or 
more respiratory viruses in 646 out of the 831 analysed specimens (77,73%). 
Interestingly, the most common viruses we found were: RSV (A and B) in 28.8% of 
positive samples, followed by HRV (26.7%), HBoV (12.23%), AdV (11%), and Flu 
A/B viruses (6.97%). In Figure 4 we show the percentage of detected viruses in 831 
analysed samples. 
 
 
Figure 4. Epidemiology of detected respiratory viruses in 831 analysed paediatric respiratory samples 
(data are expressed as percentage of the positive samples) 
 
4.2. SEASONALITY OF DETECTED RESPIRATORY VIRUSES 
The viral infections of respiratory tract were also analysed as seasonal distribution. The 
detection rate of respiratory viruses was highest in March (138/831, 21.4% of positive 
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samples) followed by January (130/831, 20.1% of positive samples) and February 
(127/831, 19.65% of positive samples), and lowest in October and November (37 and 
35/831, respectively 5.7 and 5.4% of positive samples). In Figure 5 we show the 
percentage of total detected viruses and their monthly distribution. Moreover, the rates 
for respiratory viruses in autumn, spring and winter were 9,9%, 49,5% and 40,6%, 
respectively. These data confirm previous findings that indicated a similar 
epidemiological distribution of respiratory infections (Cabello et al. 2006; Dey et al. 
2013; Leotte et al. 2017; Ge et al. 2018).  
 
Figure 5. Monthly distribution of detected respiratory viruses. Brick red is used for autumn months, 
blue for winter months and green for spring months.  
 
The detection of RSV as the most common respiratory virus in infants is also in line 
with previously reported data, as its winter seasonality (Figure 6) (Asner et al. 2014; 
Weinberg et al. 2009 Kuhdari et al. 2018; Botti et al. 2018). 
As shown in Figure 6, the pattern of prevalence of HBoV infection (found in 12% of 
positive samples) resembled the RSV infection seasonality, as previously reported 
(Manning et al. 2006; Allander et al. 2007). 
FLU viruses were found in almost 7% of the 646 positive children’s samples, with a 
strong late fall/early spring seasonality, in line with previously reported findings (Wolf 
et al. 2006; Committee on infectious diseases 2013; Centers for Disease Control and 
Prevention (CDC) 2013).  
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In contrast, HRV (found in the 27% of positive samples) and ADV (11%) are most 
commonly detected in spring. In addition, HRV is the most frequently detected virus 
in autumnal season (October/November) (Monto 2002). In Figure 6 we show 
seasonal distribution of most commonly detected respiratory viruses (RSV, ADV, 
FLU, HRV, HBoV) 
 
 
Figure 6. Seasonality of FLU, RSV, ADV, HRV, HBoV viruses 
 
4.3. CO-INFECTION OF DETECTED RESPIRATORY VIRUSES 
As reported by several studies, co-infection with respiratory viruses is often detected 
by molecular methods ( Debiaggi et al. 2012 Martínez-Roig et al. 2015). 
Indeed, analysis with AllplexTM respiratory panel assay demonstrated that 39% of the 
positive samples were co-infected with two or more viruses (Figure 7) 
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Figure 7. Percentage of viral coinfection in positive respiratory samples 
 
We have also evaluated the seasonality of respiratory viral co-infection. The data we 
obteined are also in accord with another italian study (Pierangeli et al. 2007), where the 
viral co-infections occured mainly, but not only, in the coldest months. In Figure 8 
we show the percentage of coinfection in every month. 
 
Figure 8. Monthly distribution of viral coinfection 
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4.4. TAQMAN-BASED DUPLEX REAL-TIME PCR ASSAY FOR KIHPYV 
 AND WUHPYV DETECTION SET-UP 
 4.4.1. Primer and probe design 
AllplexTM respiratory panel assay is a valuable method for the analysis of viral infection 
in respiratory samples. This assay can detect 16 viruses involved in the respiratory 
infections, but it is not designed to account for some new respiratory viruses including 
KIHPyV and WUHPyV polyomaviruses.  
Our main aim was to set up a duplex PCR for the KIHPyV and WUHPyV detection 
in respiratory viruses. 
To do so, we evaluated the genomes of KIHPyV and WUHPyV isolates deposited in 
NCBI database to design specific primers and probes (Table 6) for a duplex PCR 
using NCBI BLAST program.  
We have selected conserved sequences of KIHPyV and WUHPyV VP1 regions and 
performed BLAST (http://www.ncbi.nlm.nih.gov/BLAST) searches to check for the 
presence of known sequence variations and to rule out any cross homology to both 
other types of polyomaviruses and human sequences. 
In addition, we have compared the selected sequences of primers and probes against 
the sequences of all KIHPyV and WUHPyV deposited strains and of other human 
polyomavirus (Table 6). 
We also performed a multiple sequence alignment (MSA) using Clustal Omega as 
shown in Figures 9, 10, 11. 
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Figure 9. MSA of VP1 against another human polyomavirus 
 
Figure 10. MSA of VP1 target region against deposited KIHPV strain 
 47 
 
 
Figure 11. MSA of VP1 target region against deposited WUHPV strain 
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As shown in Figure 9, no significant homologies were detected, indicating that the 
oligonucleotides designed on VP1 region sequence of both viruses can be considered 
specific for KIHPyV and WUHPyV amplification (Figures 10, 11). 
Specific primers were selected from conserved regions corresponding to VP1 major 
capsid protein of KIHPyV (from nucleotide 1498 to 2634, 378 aa) NCBI Reference 
Sequence: NC_009238.1 and WUHPyV (from nucleotide 1670 to 2779, 369 aa) NCBI 
Reference Sequence: NC_009539.1 genome (Table 7). 
The choice of specific fluorochromes conjugated to KIHPyV or WUHPyV TaqMan 
probes allows the detection of KIHPyV and WUHPyV in 510 nm or 555 nm channels, 
respectively. 
 
Table 7 Primers and probes used for the duplex real-time PCR assay 
 
4.4.2. Duplex real time PCR set-up 
Absolute quantification was performed with standard curve method. Synthetic 
oligonucleotides were designed from nucleotide 2437 to 2518 of KIHPyV NCBI 
Reference Sequence: NC_009238.1 (82 bp) and from nucleotide 2587 to 2665 of 
WUHPyV NCBI Reference Sequence: NC_009539.1 (78 bp). We used scalar dilutions 
of synthetic positive control from 5x106 to 5x101 copies/mL as reference curves. 
The sensitivity of the duplex real-time PCR assay was determined by testing serial 
dilutions (from 5 × 105 to 5 × 101copies/mL) of two different synthetic dsDNAs 
carrying specific sequences of VP1 region of either KIHPyV (89 nt) or WUHPyV 
(90 nt). The analysis of 10 replicates of synthetic dsDNAs displayed positive detection 
in 100% samples with 5 × 102 copies/mL (approximately 17 copies/reaction) for 
either KIHPyV or WUHPyV (Table 8). 
  
Primer 
probe name 
Primer/probe sequence Gene target Gene position 
KIF 5’-CAAGTGTTTAACAGACCCACAGAAAC-3’ KIPyV- VP1 939-965 
KIR 5’-GTGGGCCTATTTCTTCTACCATAGTC- 3’ KIPyV- VP1 996-1021 
FAM-KI MGB 5’-TGATGCACAGGTTGGT-3’ KIPyV- VP1 969-984 
WUF 5’-GGTGTTTAATAAGCCAGCTGATGA-3’ WUPyV-VP1 918-941 
WUR 5’-GGGCCCTGTTTCTTCAGTCA-3’ WUPyV-VP1 977-996 
VIC-WU MGB 5’-TAGTGGGCAACTGC-3’ WUPyV-VP1 945-958 
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Synthetic DNA target 
(copy number/mL) 
Number of positive 
replicates/ 
Total replicates 
% 
KIHPyV 
5x105 10/10 100 
5x104 10/10 100 
5x103 10/10 100 
5x102 10/10 100 
5x101 1/10 10 
0 0/10 0 
WUHPyV 
5x105 10/10 100 
5x104 10/10 100 
5x103 10/10 100 
5x102 10/10 100 
5x101 1/10 10 
0 0/10 0 
Table 8. Analysis of scalar dilution replicates 
 
In the next series of replicates (5 × 102, 4 × 102, 3 × 102, 2 × 102, 1 × 102, 5 × 101 
copies/mL), linear regression analysis with Probit model analysis has been calculated. 
The limit of detection in at least the 95% of replicates was determined at 328 
copies/mL (12 copies/reaction) with a 95% confidence interval from 256 to 444 for 
KIHPyV and 345 copies/mL (15 copies/reaction) with a 95% confidence interval 
from 284 to 472 for WUHPyV(Table 9). 
 
 
Synthetic DNA target 
(copy number/mL) 
Number of positive replicates 
Total replicates 
% 
KIHPyV 
5x102 10/10 100 
4x102 10/10 100 
3x102 10/10 100 
2x102 4/10 40 
1x102 3/10 30 
5x101 1/10 10 
WUHPyV 
5x102 10/10 100 
4x102 10/10 100 
3x102 9/10 90 
2x102 4/10 40 
1x102 2/10 20 
5x101 1/10 10 
Table 9. Probit analysis 
 
Our assay showed an efficiency >90% with a correlation coefficient R2 > 0.99 for both 
the viral targets. The linearity of this assay is detectable in 10-fold scalar dilutions (n = 5 
for each dilution) from 5 × 106 copies/mL to 5 × 102copies/mL. The specificity of the 
duplex real-time PCR assay was verified by examining negative controls and positive 
samples for different respiratory viruses including Flu A, Flu B, PIV, AdV, HRV, RSV 
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A, RSV B, HBoV, CoV, MPV and HEVs (n = 3 for each virus). Not all these samples 
showed positive signals for either KIHPyV or WUHPyV determination. 
The intra-assay and inter-assay analyses were performed in serial dilutions of synthetic 
dsDNA targets. We assayed intra-assay analysis with 10-fold serial dilutions (from 
5 × 106 copies/mL to 5 × 102 copies/mL) of dsDNA specific for KIHPyV or 
WUHPyV in triplicate. The intra-assay and inter-assay reproducibility data are 
indicated in table 10 and 11. 
The coefficient of variation (CV) calculated on average Ct was lower than 2% for all 
dilutions of either KIHPyV or WUHPyV. Similarly, we have compared the data 
obtained in three separate experiments performed in triplicate for the inter-assay 
evaluation. The results showed a coefficient of variation lower than 3% for all scalar 
dilutions for either KIHPyV or WUHPyV.  
 
KIHPyV (copies/ml) Ct (mean) Standard Deviation (SD) Coefficient of Variation (%) 
5x106 22.31 0.28 1.2 
5x105 25.52 0.27 1.1 
5x104 28.92 0.41 1.4 
5x103 33.12 0.32 1 
5x102 36.81 0.47 1.2 
WUHPyV (copies/ml) Ct (mean) Standard Deviation (SD) Coefficient of Variation (%) 
5x106 22.12 0.37 1.7 
5x105 25.26 0.22 0.9 
5x104 28.56 0.26 0.9 
5x103 32.41 0.22 0.7 
5x102 36.1 0.48 1.3 
Table 10. Intra-assay analysis 
 
KIHPyV (copies/ml) Ct (mean) Standard Deviation (SD) Coefficient of Variation (%) 
5x106 22.46 0.35 1.57 
5x105 25.87 0.54 2.08 
5x104 29.13 0.44 1.53 
5x103 32.96 0.51 1.55 
5x102 36.74 0.58 1.57 
WUHPyV (copies/ml) Ct (mean) Standard Deviation (SD) Coefficient of Variation (%) 
5x106 22.26 0.37 1.72 
5x105 25.61 0.36 1.42 
5x104 28.78 0.39 1.36 
5x103 32.55 0.36 1.12 
5x102 36.32 0.43 1.19 
Table 11 Inter-assay analysis 
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As the presence of very different concentrations of viral targets in duplex PCR can 
interfere on sensitivity reaction, we combined a high concentration (106 copies/mL) 
and a low concentration (103 copies/mL) of synthetic target of KIHPyV and 
WUHPyV in an interference test.  
The results obtained did not show systematic difference in the amplification curves of 
the mixed targets with respect to the run performed with a single target (Table 12). 
The CV mean value showed a difference lower than 2%, suggesting a low interference 
when different template concentrations of targets were simultaneously amplified. 
 
Synthetic oligo samples KIHPyV Ct mean WUHPyV Ct mean 
KIHPyV (103 copies/ml) 32.31 - 
KIHPyV (106 copies/ml) 21.57 - 
WUHPyV (103 copies/ml) - 35.03 
WUHPyV (106 copies/ml) - 21.22 
KIHPyV (103 copies/ml) + 
WUHPyV (106 copies/ml) 
33.07 21.34 
KIHPyV (106 copies/ml) + 
WUHPyV (103 copies/ml) 
21.7 35.89 
Table 12. Analysis of duplex PCR amplification in simultaneous presence of different target 
concentrations 
 
Several conventional PCR methods have been previously assessed for separate 
identification of WUHPyV and KIHPyV  
Although TaqMan-based PCR assay is the most rapid, specific and sensitive approach 
for the detection/discrimination of KIHPyV and WUHPyV. Our original method has 
a higher sensitivity and a specificity comparable to other published Single-Tube Real-
Time PCR methods (Lindau et al. 2009).  
 
 4.4.3. KIHPyV and WUHPyV analysis in 831 clinical samples 
To validate our assay, the same 831 clinical samples collected from paediatric patients 
followed at the Hospital of Verona between 2016 and 2018 were analysed for detection 
of KI and WU Human Polyomaviruses.  
Our data indicated that 28 out of 831 samples (3.36%) were positive for KIHPyV 
whereas WUHPyV was detected in 41 out of 831 samples (4.93%) (Figure 12). 
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Figure 12. Percentage of KIHPyV /WUHPyV positive samples in analysed pediatric samples 
 
Our results are in line with previously published epidemiological studies, and also 
confirms that the prevalence of WUHPyV is higher than KIHPyV as previously 
indicated (Ramqvist et al. 2009). 
The quantitative data (Figure 13) of viral load on respiratory samples displayed 
different amounts of KIHPyV and WUHPyV genomes in respiratory samples. The 
KIHPyV viral load in positive samples was detected between 5.71 × 102 and more than 
1 × 108 copies/mL with a median value of 16017 copies/mL, whereas the WUHPyV 
viral load in positive specimens was calculated between 4.09 × 102 and more than 
1 × 108 copies/mL with a median value of 214786 copies/mL. 
 
 
Figure 13. KIPHyV and WUHPyV quantification 
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  4.4.3.1 KIHPyV and WUHPyV coinfection 
The association between KIHPyV and/or WUHPyV infections and respiratory 
diseases is controversial because these two viruses showed very high co-infection rates 
with other respiratory viruses increasing the complexity of KIPyV and/or WUHPyV 
roles in the respiratory pathogenesis. 
Since that, we determined whether the KIHPyV and/or WUHPyV positive samples 
showed viral co-infections by analysing the data obtained with commercial Allplex™ 
respiratory panel assay kit. This analysis displayed that 20 out of 28 KIHPyV positive 
samples showed one or more viral co-infections, whereas WUHPyV was associated to 
other viruses in 35 out of 41 cases. Thus, in 8 cases KIHPyV was the only virus 
identified, while in 6 cases this was true for WUHPyV. Interestingly, KIHPyV is 
preferentially associated with HRV (17 out of 20 co-infected samples) followed by 
HBoV and AdV (6 out of 20 samples). In Figure 14, we show the percentage of 
KIHPyV coinfection. On other hand, WUHPyV exhibited a major association with 
HRV (16 out of 35 co-infected samples) followed by RSV A/B viruses (10 out of 35 
samples) and AdV (8 out of 35 samples). In Figure 15, we show the percentage of 
WUHPyV coinfection. It is noteworthy that KIHPyV and WUHPyV were 
simultaneously detected in three samples (Figure 16), in association with at least 
another respiratory virus. 
 
 
Figure 14. KIHPyV coinfection 
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Figure 15. WUHPyV coinfection 
 
 
Figure 16. KIHPyV and WUHPyV double positive samples 
 
  4.4.3.2 KIPHyV and WUHPyV seasonal distribution 
We also analysed the seasonal distribution of KIHPyV and WUHPyV in our patients. 
As shown in Figure 17 and 18, the two viruses were detected more frequently in spring. 
This is probably due to the high co-infection rate of these two polyomaviruses with 
HRV and HBoV, that were the more frequently detected viruses in the same season. 
This seasonal pattern is similar to the distribution observed by Han and co-workers 
(Han et al. 2007b) whereas Ramqvist and colleagues showed a wider distribution of 
these two viruses (Ramqvist et al. 2009). 
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Figure 17 Monthly distribution of KIHPyV and WUHPyV 
 
  
Figure 18. Seasonal distribution of KIHPyV and WUHPyV 
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5 DISCUSSION 
 
Viral respiratory tract infection can lead to a series of respiratory tract diseases ranging 
from simple rhinitis to pneumonia. 
These respiratory viral diseases are very important at both pathogenic and clinical point 
of view, because the cellular and tissue damage induced by the viral infection itself can 
determine the conditions for a bacterial co-infection leading to more serious clinical 
conditions. 
The morbidity and mortality of viral respiratory infections are very important, 
especially in children, elderly, immunosuppressed and transplant patients where viruses 
such as FLU Virus and RSV may result in severe symptomatology leading, in most 
severe cases, to patient’s death. 
In this study, our objective was the identification and epidemiologic characterization 
of two recently isolated viruses, the Polyomaviridae KIHPyV and WUHPyV, using a new 
molecular method. 
In particular, this study allowed defining:  
I. A new Duplex real-time quantitative PCR method for the direct molecular 
identification of KIHPyV and WUHPyV; 
II. Validation of this method retrospectively on a cohort of paediatric patients 
with respiratory disorders. The nasopharyngeal aspirate samples were also 
analysed by a commercial Multiplex PCR method identifying 16 respiratory 
viruses placed in three distinct panels; 
III. Local epidemiological study of both these two viruses and other 16 respiratory 
viruses; 
IV. Epidemiological study of the co-infection with the 16 respiratory viruses, 
KIHPyV and WUHPyV. 
We set-up a Duplex real time PCR method based on a TaqMan system. Our original 
method is based on the amplification of the most conserved region of HHPyV 
genome, VP1, that in the past was also considered as an ideal region for the single 
amplification of these two viruses.  
As previously described (Bialasiewicz et al 2007; Bergallo et al 2009), the location of 
primer and probe sequences can affect KIHPyV and WUHPyV detection rates. 
Indeed, in the KIHPyV VP1 region (Bergallo et al., 2009), primers and probes located 
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in the sTAG or regulatory regions have been investigated. Hence, we selected VP1 
domain of the two viruses as target region for our original Duplex real-time PCR in 
order to optimize both sensitivity and specificity. In fact, our method allows the 
detection of up to 500 copies/mL equal to 17 copies/reaction in all the replicates of 
the two viruses, with a sensitivity comparable to described single amplification assays. 
Several conventional PCR methods have been previously assessed for separate 
identification of WUHPyV and KIHPyV ( Abed et al. 2007; Abedi Kiasari et al. 2008; 
Foulongne et al. 2008; Neske et al. 2008), but sensitivity hasn’t been often evaluated. 
Other authors describe conventional PCR methods followed by sequencing (Norja et 
al. 2007) but besides the longer time required and the higher risk of contamination, 
conventional end-point PCR also shows a lower sensitivity than Real-Time PCR. Data 
acquisition in Real-time PCR is made during linear phase or in early log-phase where 
conditions are optimal, instead of the end-point acquisition that could be affected by 
poorly optimized conditions or saturation of inhibitory PCR products or amplicons 
(Bergallo et al. 2009). Real-Time PCR for the separate identification of KIHPyV and 
WUHPyV (Bialasiewicz et al. 2007; Bergallo et al. 2009; Rao et al. 2011) and Real-Time 
PCR methods based on melting curve analysis have been published (Payungporn, et 
al. 2008), but these assays are not able to co-detect KIHPyV and WUHPyV in the 
same samples, because the melting curves would not be distinguished. 
TaqMan-based PCR assay is a specific and sensitive approach for the 
detection/discrimination of KIHPyV and WUHPyV, and our original method has a 
higher sensitivity and comparable specificity to other published Single-Tube Real-Time 
PCR methods (Lindau et al. 2009). For these reasons, our method could be strongly 
taken into account as an alternative technical approach to detect KIHPyV and/or 
WUHPyV in respiratory samples for epidemiological and diagnostic analyses. 
To validate our assay, we retrospectively analysed 831 clinical samples collected from 
paediatric patients admitted to Verona Hospital, Italy during 2016-2018 for detection 
of KI and WU Human Polyomaviruses. These samples had also been analysed for the 
detection of other conventional respiratory viruses with the Allplex™ respiratory panel 
assay kit able to determine the 16 major viruses associated to respiratory infection 
through three specific panels. 
Our data indicated that 28 out of 831 samples (3.37%) were positive for KIHPyV 
whereas WUHPyV was detected in 41 out of 831 samples (4.93%). These results are 
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in line with previously published epidemiological studies. In fact, in patients with 
respiratory symptoms the prevalence of KIHPyV varied from 0.5 to 7%, whereas the 
prevalence of WUHPyV varied from 0.4 to 9% (Abedi Kiasari et al. 2008; van der 
Zalm et al. 2008; Essa et al. 2015; Gozalo-Margüello et al. 2015; Essa et al. 2017; Zhu 
et al. 2017) in immunocompetent paediatric/adult population. Our data also confirmed 
that the prevalence of WUHPyV is higher than KIHPyV as previously indicated 
(Ramqvist et al. 2009). Differences in prevalence described in past studies may be 
related to either regional prevalence variations or age population selection. In 
particular, a higher detection of KIHPyV and WUHPyV in respiratory samples of 
pediatric patients than in adult patients was noticed (Csoma et al. 2015; Abedi Kiasari 
et al. 2008). 
Our results suggest that infection with these two viruses should be carefully considered 
as a leading cause of respiratory disease. The importance of KIHPyV and WUHPyV 
as etiological agents of respiratory pathology is currently controversial because 
previous studies showed that co-infection with other respiratory viruses is common in 
both KIHPyV- and WUHPyV-positive samples. The high rates of co-infection may 
support the notion that KIPHyV and WUHPyV do not have a truly significant 
pathogenic action (Wattier et al., 2008). Our data displayed that 20 out of 28 KIHPyV 
positive samples showed one or more viral co-infections, whereas WUHPyV was 
associated to other viruses in 35 out of 41 cases. In our cohort, KIHPyV is 
preferentially associated with HRV (17 out of 20 co-infected samples) followed by 
HBoV and ADV (6 out of 20 samples) (Figure 13A). On the other hand, WUHPyV 
exhibited a major association with HRV (16 out of 35 co-infected samples) followed 
by RSV A/B viruses (10 out of 35 samples) and ADV (8 out of 35 samples). Moreover, 
in 3 cases KIPHyV and WUHPyV are both present, in association also with other 
viruses. It is very important to note that there are 14 cases in which KIPHyV and 
WUHPyV are present individually (8 and 6 cases, respectively).  
This observation confirms some previous studies (Han et al., 2007, Kleines et al., 2009) 
in which KIHPyV and WUHPyV could be detected as a single infection in patients 
with severe acute respiratory illnesses.  
Although there are no clear evidences, the possibility that these viruses may establish 
persistent replication in immunocompetent hosts and may elicit respiratory disorders 
is suggested. Furthermore, we have to consider how the complex interaction between 
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the biology of these viruses and host clinical status can act in development of 
respiratory tract infection, as there may be several acute, persistent and chronic 
conditions of infection that contribute to a very hard-to-interpret scenario. 
For example, not only viral coinfections but also the immunological status of the 
patients themselves can play an important role in the evolution of the infection and on 
its clinical outcome. It is worth mentioning that immunocompromised patients show 
increased viral load values and a tendency to infection persistence (Mourez et al. 2009; 
Rao et al. 2011). 
In conclusion, this study allowed the investigation of some methodological aspects in 
the diagnosis of the two newly identified KIHPyV and WUHPyV. Our new method 
of Duplex real-time PCR based on TaqMan technology allows a simultaneous 
quantitative evaluation of the presence of these two viruses. The inter- and intra-assay 
tests confirmed the high sensitivity, specificity and repeatability of the system that was 
appropriately validated on clinical samples. This indicates that this original 
methodological approach can be considered as an alternative method to classical PCR 
methods, showing some advantages such as the simultaneous evaluation of the two 
viruses and a high sensitivity comparable to conventional PCR molecular methods. 
This study also provides important observations on the epidemiological side: to our 
knowledge, this is the first study that describes at a local level the prevalence of these 
two viruses in paediatric patients with respiratory symptoms, suggesting how these two 
viruses can be considered as part of the basic virological screening when viral aetiology 
of a respiratory pathology is suspected. 
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